150 related articles for article (PubMed ID: 7527332)
1. Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5.
Arai T; Arai A; Busby WH; Clemmons DR
Endocrinology; 1994 Dec; 135(6):2358-63. PubMed ID: 7527332
[TBL] [Abstract][Full Text] [Related]
2. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans.
Yang YW; Yanagishita M; Rechler MM
Endocrinology; 1996 Oct; 137(10):4363-71. PubMed ID: 8828497
[TBL] [Abstract][Full Text] [Related]
3. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes.
Arai T; Parker A; Busby W; Clemmons DR
J Biol Chem; 1994 Aug; 269(32):20388-93. PubMed ID: 7519608
[TBL] [Abstract][Full Text] [Related]
4. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I.
Nam TJ; Busby W; Clemmons DR
Endocrinology; 1997 Jul; 138(7):2972-8. PubMed ID: 9202242
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms.
Martin JL; Ballesteros M; Baxter RC
Endocrinology; 1992 Oct; 131(4):1703-10. PubMed ID: 1382959
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth.
Nam TJ; Busby WH; Rees C; Clemmons DR
Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186
[TBL] [Abstract][Full Text] [Related]
8. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures.
Munteanu SE; Ilic MZ; Handley CJ
Matrix Biol; 2002 Aug; 21(5):429-40. PubMed ID: 12225808
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts.
Fowlkes J; Freemark M
Endocrinology; 1992 Nov; 131(5):2071-6. PubMed ID: 1385096
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb.
Russo VC; Bach LA; Fosang AJ; Baker NL; Werther GA
Endocrinology; 1997 Nov; 138(11):4858-67. PubMed ID: 9348216
[TBL] [Abstract][Full Text] [Related]
11. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5.
Nam TJ; Busby WH; Clemmons DR
Endocrinology; 1994 Oct; 135(4):1385-91. PubMed ID: 7523096
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I (IGF-I) enhanced proteolysis of IGF-binding protein-4 in conditioned medium from primary cultures of human decidua: independence from IGF receptor binding.
Myers SE; Cheung PT; Handwerger S; Chernausek SD
Endocrinology; 1993 Oct; 133(4):1525-31. PubMed ID: 7691578
[TBL] [Abstract][Full Text] [Related]
13. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis.
Irwin JC; Dsupin BA; Giudice LC
J Clin Endocrinol Metab; 1995 Feb; 80(2):619-26. PubMed ID: 7531715
[TBL] [Abstract][Full Text] [Related]
14. Sulfated glycosaminoglycans modify growth factor-induced neurite outgrowth in PC12 cells.
Damon DH; D'Amore PA; Wagner JA
J Cell Physiol; 1988 May; 135(2):293-300. PubMed ID: 2967302
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
[TBL] [Abstract][Full Text] [Related]
16. Influence of exogenous glycosaminoglycans on growth and glycosaminoglycan synthesis of cultured human diploid fibroblasts (WI-38).
Schachtschabel DO; Wever J; Sluke G; Wever G
Z Gerontol; 1979; 12(1):19-26. PubMed ID: 433377
[TBL] [Abstract][Full Text] [Related]
17. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: studies of underlying mechanisms.
Mazerbourg S; Zapf J; Bar RS; Brigstock DR; Lalou C; Binoux M; Monget P
Endocrinology; 1999 Sep; 140(9):4175-84. PubMed ID: 10465290
[TBL] [Abstract][Full Text] [Related]
19. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.
Booth BA; Boes M; Andress DL; Dake BL; Kiefer MC; Maack C; Linhardt RJ; Bar K; Caldwell EE; Weiler J
Growth Regul; 1995 Mar; 5(1):1-17. PubMed ID: 7538367
[TBL] [Abstract][Full Text] [Related]
20. Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts.
Nam TJ; Busby WH; Clemmons DR
Endocrinology; 1996 Dec; 137(12):5530-6. PubMed ID: 8940380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
